Literature DB >> 16145076

Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size.

Wendy W J van de Sande1, Roy Gorkink, Guus Simons, Alewijn Ott, Abdalla O A Ahmed, Henri Verbrugh, Alex van Belkum.   

Abstract

One of the causative organisms of mycetoma is the fungus Madurella mycetomatis. Previously, extensive molecular typing studies identified Sudanese isolates of this fungus as clonal, but polymorphic genetic markers have not yet been identified. Here, we report on the selective amplification of restriction fragment (AFLP) analysis of 37 Sudanese clinical isolates of M. mycetomatis. Of 93 AFLP fragments generated, 25 were polymorphic, and 12 of these 25 polymorphic fragments were found in a large fraction of the strains. Comparative analysis resulted into a tree, composed of two main (clusters I and II) and one minor cluster (cluster III). Seventy-five percent of the strains found in cluster I originated from central Sudan, while the origin of the strains in cluster II was more heterogeneous. Furthermore, the strains found in cluster I were generally obtained from lesions larger than those from which the strains found in cluster II were obtained (chi-square test for trend, P = 0.03). Among the 12 more commonly found polymorphisms, 4 showed sequence homology with known genes. Marker A7 was homologous to an endo-1,4-beta-glucanase from Aspergillus oryzae, 97% identical markers A12 and B3 matched a hypothetical protein from Gibberella zeae, and marker B4 was homologous to casein kinase I from Danio rerio. The last marker seemed to be associated with strains originating from central Sudan (P = 0.001). This is the first report on a genotypic study where genetic markers which may be used to study pathogenicity in M. mycetomatis were obtained.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145076      PMCID: PMC1234066          DOI: 10.1128/JCM.43.9.4349-4356.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan.

Authors:  Abdalla Ahmed; Daniel Adelmann; Ahmed Fahal; Henri Verbrugh; Alex van Belkum; Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization.

Authors:  D M Milne; P Looby; D W Meek
Journal:  Exp Cell Res       Date:  2001-02-01       Impact factor: 3.905

3.  Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.

Authors:  Wendy W J van de Sande; Ad Luijendijk; Abdalla O A Ahmed; Irma A J M Bakker-Woudenberg; Alex van Belkum
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  [Mycetoma: 130 cases].

Authors:  M-T Dieng; M-H Sy; B-M Diop; S-O Niang; B Ndiaye
Journal:  Ann Dermatol Venereol       Date:  2003-01       Impact factor: 0.777

5.  [Mycetomas in central Tunisia].

Authors:  M Denguezli; M Kourda; N Ghariani; C Belajouza; B Mokni; F Chebil; B Riahi; B Jomaa; R Nouira
Journal:  Ann Dermatol Venereol       Date:  2003-05       Impact factor: 0.777

6.  Clonal reproduction and limited dispersal in an environmental population of Cryptococcus neoformans var gattii isolates from Australia.

Authors:  C L Halliday; D A Carter
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reesei.

Authors:  Pamela K Foreman; Doug Brown; Lydia Dankmeyer; Ralph Dean; Stephen Diener; Nigel S Dunn-Coleman; Frits Goedegebuur; Thomas D Houfek; George J England; Aaron S Kelley; Hendrik J Meerman; Thomas Mitchell; Colin Mitchinson; Heather A Olivares; Pauline J M Teunissen; Jian Yao; Michael Ward
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

8.  Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.

Authors:  Abdalla Ahmed; Wendy van de Sande; Henri Verbrugh; Ahmed Fahal; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains.

Authors:  Adilia Warris; Corné H W Klaassen; Jacques F G M Meis; Maaike T De Ruiter; Hanneke A De Valk; Tore G Abrahamsen; Peter Gaustad; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  double-time is identical to discs overgrown, which is required for cell survival, proliferation and growth arrest in Drosophila imaginal discs.

Authors:  O Zilian; E Frei; R Burke; D Brentrup; T Gutjahr; P J Bryant; M Noll
Journal:  Development       Date:  1999-12       Impact factor: 6.868

View more
  17 in total

1.  Phenotypic and molecular characterization of Madurella pseudomycetomatis sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma.

Authors:  Jie Yan; Jun Deng; Cun-Jian Zhou; Bai-Yu Zhong; Fei Hao
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

2.  Subcutaneous fungal infections.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

3.  Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.

Authors:  Wendy W J van de Sande; Ahmed H Fahal; Irma A J M Bakker-Woudenberg; Alex van Belkum
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

4.  Molecular identification of black-grain mycetoma agents.

Authors:  Marie Desnos-Ollivier; Stéphane Bretagne; Françoise Dromer; Olivier Lortholary; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.

Authors:  Alex van Belkum; Ahmed H Fahal; Wendy W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

6.  A Short-Tandem-Repeat Assay (MmySTR) for Studying Genetic Variation in Madurella mycetomatis.

Authors:  Bertrand Nyuykonge; Kimberly Eadie; Willemien H A Zandijk; Sarah A Ahmed; Marie Desnos-Ollivier; Ahmed H Fahal; Sybren de Hoog; Annelies Verbon; Wendy W J van de Sande; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

7.  In vitro antifungal activity of isavuconazole against Madurella mycetomatis.

Authors:  Wendy Kloezen; Jacques F Meis; Ilse Curfs-Breuker; Ahmed H Fahal; Wendy W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

8.  The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.

Authors:  Mickey Konings; Kimberly Eadie; Wilson Lim; Ahmed H Fahal; Johan Mouton; Nicolas Tesse; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2021-06-09

9.  Association of eumycetoma and schistosomiasis.

Authors:  Jaap J van Hellemond; Alieke G Vonk; Corné de Vogel; Rob Koelewijn; Norbert Vaessen; Ahmed H Fahal; Alex van Belkum; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2013-05-23

10.  Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.

Authors:  Wilson Lim; Mickey Konings; Florianne Parel; Kimberly Eadie; Nikolaos Strepis; Ahmed Fahal; Annelies Verbon; Wendy W J van de Sande
Journal:  Med Mycol       Date:  2022-02-02       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.